ArticleJournal of molecular medicine (Berlin, Germany)2015

BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.

L Flanagan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.